• About Us
    • Who We Are
    • Our History
    • Mission & Values
    • Why Choose Jost
  • Products
    • Ammonium
    • Calcium
    • Copper
    • Iron
    • Magnesium
    • Manganese
    • Potassium
    • Sodium
    • Strontium
    • Zinc
    • Ultra Pure Minerals (Low Heavy Metals)
    • Infant Pure (Low Chlorate Minerals)
    • Pharma Pure
    • JOSTCOTE® Microencapsulated
    • New Products
    • Custom Products
  • Our Expertise
    • cGMP Manufacturing
    • Quality
    • Research & Development
    • Customer Service
  • Markets
    • Nutritional
    • Pharmaceutical / Biotech
    • Specialty
  • Media
    • Library
    • News
    • Events
    • Videos
  • Technical Info
    • Technical Resources
    • Links
  • Contact Us
    • Sales & Customer Service
    • Our Locations
  • Careers
Jost Chemical Co.
  • FAQ
  • Download Catalog
  • 314-428-4300
  • About Us
    • Who We Are
    • Our History
    • Mission & Values
    • Why Choose Jost
  • Products
    • Ammonium
    • Calcium
    • Copper
    • Iron
    • Magnesium
    • Manganese
    • Potassium
    • Sodium
    • Strontium
    • Zinc
    • Ultra Pure Minerals (Low Heavy Metals)
    • Infant Pure (Low Chlorate Minerals)
    • Pharma Pure
    • JOSTCOTE® Microencapsulated
    • New Products
    • Custom Products
  • Our Expertise
    • cGMP Manufacturing
    • Quality
    • Research & Development
    • Customer Service
  • Markets
    • Nutritional
    • Pharmaceutical / Biotech
    • Specialty
  • Media
    • Library
    • News
    • Events
    • Videos
  • Technical Info
    • Technical Resources
    • Links
  • Contact Us
    • Sales & Customer Service
    • Our Locations
  • Careers
Home › Related Articles › Supplementation trials with calcium citrate malate: evidence in favor of increasing the calcium RDA during childhood and adolescence
J Nutr. 1994 Aug

Supplementation trials with calcium citrate malate: evidence in favor of increasing the calcium RDA during childhood and adolescence

Abstract:

The vast majority of peak adult bone mass is accumulated by the time longitudinal growth is complete. As peak bone mass is an important determinant of future fracture risk, the goal of the current calcium recommended dietary allowance during youth is to provide a calcium intake that allows individuals to reach their full genetic potential for acquiring skeletal mass. The advent of controlled trials of calcium supplementation and total body bone mass measurements in children and adolescents provide the first direct way of determining the amount of calcium necessary to achieve optimal skeletal accretion. These studies indicate that the current RDAs are insufficient to support optimal bone mass gain during growth and development. Based on the recent intervention trials, recommendations are made for an RDA of 1250 mg during childhood and 1450 mg during adolescence. These values are consistent with established calcium balance intake thresholds for growth during pre-adolescence and adolescence.

PMID 8064394  /  M B Andon, T Lloyd, V Matkovic

Related Products
  • Library
  • News
    • Company News
    • Product Development
    • Industry News
    • Awards
  • Events
  • Videos

Learn about new Jost products and events.
subscribe

  • Who We Are
  • Products
  • Documents
  • News
  • Contact
  • Careers
  • Spanish
  • German
  • French

Follow Us

  • linkedin
  • facebook

Jost Chemical Co.
(The Americas and Asia)
8150 Lackland
St. Louis, MO 63114
Tel: +1 314 428 4300
Fax: +1 314 428 4366
customer.service@jostchemical.comcustomer.service@jostchemical.com

Jost Chemical Poland sp. z o.o
(Europe, Middle East and Africa)
ul. gen. Kazimierza Pułaskiego 7
64-000 Kościan, Poland
Tel: +48 65 322 69 00
Fax: +48 65 322 69 06
customer.service@jostchemical.comcustserv@jostchemical.com

Sitemap     Cookies     Terms of Use

Copyright © 1995–2025 Jost Chemical Co. All rights reserved.